Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Blazing · SciRah

Researcher profile · Semantic Scholar

M. Blazing

Share profile

M. Blazing — researcher profile on SciRah

h-index: 54
Works: 179
Citations: 16K

Most-cited papers

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
C. Cannon, M. Blazing, R. Giugliano, A. McCagg +17 more
2015New England Journal of Medicine3,018 citations Open access
Semantic Scholar
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
D. Preiss, S. Seshasai, P. Welsh, S. Murphy +14 more
2011Journal of the American Medical Association (JAMA)1,230 citations
Semantic Scholar
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
J. Armitage, C. Baigent, E. Barnes, D. Betteridge +95 more
2019The Lancet594 citations Open access
Semantic Scholar
Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy
J. A. de Lemos, E. Braunwald, M. Blazing, S. Murphy +113 more
2012PLoS ONE343 citations Open access
Semantic Scholar
Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
E. Bohula, R. Giugliano, C. Cannon, Jing Zhou +5 more
2015Circulation322 citations
Semantic Scholar
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
C. Cannon, R. Giugliano, M. Blazing, R. Harrington +8 more
2008American Heart Journal306 citations
Semantic Scholar
Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial
D. Morrow, J. A. de Lemos, M. Sabatine, S. Wiviott +5 more
2006Circulation304 citations Open access
Semantic Scholar
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes Vytorin Efficacy International Trial)
R. Giugliano, C. Cannon, M. Blazing, J. Nicolau +6 more
2018Circulation223 citations
Semantic Scholar
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
M. Blazing, E. Braunwald, J. A. de Lemos, S. Murphy +106 more
2022The Lancet218 citations Open access
Semantic Scholar
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.
Nicholas A. Marston, R. Giugliano, G. Melloni, Jeong-Gun Park +10 more
2021JAMA cardiology215 citations Open access
Semantic Scholar
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
S. Murphy, C. Cannon, M. Blazing, R. Giugliano +11 more
2016Journal of the American College of Cardiology204 citations Open access
Semantic Scholar
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.
E. Bohula, David A. Morrow, Robert P. Giugliano, M. Blazing +10 more
2017Journal of the American College of Cardiology196 citations Open access
Semantic Scholar
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol: A Prespecified Analysis of the IMPROVE-IT Trial
R. Giugliano, S. Wiviott, M. Blazing, G. D. de Ferrari +6 more
2017JAMA cardiology191 citations Open access
Semantic Scholar
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
J. A. de Lemos, D. Morrow, M. Blazing, P. Jarolím +4 more
2007Journal of the American College of Cardiology183 citations Open access
Semantic Scholar
Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials.
M. Briel, G. Schwartz, P. Thompson, J. A. de Lemos +12 more
2006Journal of the American Medical Association (JAMA)161 citations
Semantic Scholar
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT
R. Giugliano, C. Cannon, M. Blazing, J. Nicolau +6 more
2017150 citations
Semantic Scholar
Prospective assessment of radiotherapy‐associated cardiac toxicity in breast cancer patients: Analysis of data 3 to 6 years after treatment
Robert G. Prosnitz, Jessica L. Hubbs, E. S. Evans, Su-Min Zhou +8 more
2007Cancer148 citations Open access
Semantic Scholar
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial.
Marc P. Bonaca, J. A. Gutierrez, C. Cannon, R. Giugliano +5 more
2018The Lancet Diabetes and Endocrinology125 citations
Semantic Scholar
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
E. Bohula, S. Wiviott, R. Giugliano, M. Blazing +10 more
2017Circulation123 citations Open access
Semantic Scholar
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.
R. Bach, C. Cannon, R. Giugliano, Jennifer A. White +5 more
2019JAMA cardiology114 citations Open access
Semantic Scholar
A Tale of Two Trials: A Comparison of the Post–Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT–TIMI 22
S. Wiviott, J. A. de Lemos, C. Cannon, M. Blazing +4 more
2006Circulation113 citations
Semantic Scholar
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
C. Reith, David Preiss, L. Blackwell, J. Emberson +128 more
2024The Lancet Diabetes and Endocrinology108 citations Open access
Semantic Scholar
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
Eri Toda Kato, D. Morrow, Jianping Guo, D. Berg +16 more
2022European Heart Journal105 citations Open access
Semantic Scholar
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population.
M. Blazing, R. Giugliano, C. Cannon, T. Musliner +6 more
2014American Heart Journal100 citations Open access
Semantic Scholar
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.
R. Califf, Y. Lokhnygina, C. Cannon, M. Stepanavage +7 more
2010American Heart Journal100 citations
Semantic Scholar
Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial
P. Tricoci, D. D'Andrea, P. Gurbel, Z. Yao +12 more
2015Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease98 citations Open access
Semantic Scholar
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
S. Murphy, C. Cannon, S. Wiviott, J. A. de Lemos +4 more
2007American Journal of Cardiology91 citations
Semantic Scholar
Effects of coping skills training and sertraline in patients with non-cardiac chest pain: A randomized controlled study
F. Keefe, R. Shelby, Tamara J. Somers, I. Varia +10 more
2011Pain89 citations Open access
Semantic Scholar
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial.
A. Eisen, C. Cannon, M. Blazing, E. Bohula +5 more
2016European Heart Journal80 citations
Semantic Scholar
The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
Tracey G. Simon, K. Corey, C. Cannon, M. Blazing +4 more
2018International Journal of Cardiology62 citations Open access
Semantic Scholar
Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Eri Toda Kato, C. Cannon, M. Blazing, E. Bohula +6 more
2017Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease60 citations Open access
Semantic Scholar
Splanchnic nerve block for decompensated chronic heart failure: splanchnic-HF
M. Fudim, Arun Ganesh, C. Green, W. Jones +8 more
2018European Heart Journal57 citations Open access
Semantic Scholar
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome.
L. Mielniczuk, M. Pfeffer, E. Lewis, M. Blazing +5 more
2008American Heart Journal52 citations
Semantic Scholar
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
E. Brilakis, J. A. de Lemos, C. Cannon, S. Wiviott +7 more
2008American Journal of Cardiology48 citations
Semantic Scholar
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations
Nishant P. Shah, Neha J. Pajidipati, R. McGarrah, A. Navar +5 more
2020American Journal of Cardiology45 citations Open access
Semantic Scholar
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
K. Oyama, R. Giugliano, M. Blazing, Jeong-Gun Park +4 more
2021Journal of the American College of Cardiology44 citations Open access
Semantic Scholar
Management of Hyperlipidemia in Older Adults
K. Alexander, M. Blazing, R. S. Rosenson, E. Hazard +3 more
2009Journal of Cardiovascular Pharmacology and Therapeutics42 citations
Semantic Scholar
Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.
Dalton S. Mclean, S. Ravid, M. Blazing, B. Gersh +2 more
2008American Heart Journal40 citations
Semantic Scholar
Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.
John W. Stanifer, D. Charytan, Jennifer A. White, Y. Lokhnygina +3 more
2017Journal of the American Society of Nephrology35 citations Open access
Semantic Scholar
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.
Arman Qamar, R. Giugliano, E. Bohula, Jeong-Gun Park +7 more
2019Journal of the American College of Cardiology31 citations Open access
Semantic Scholar
Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome.
L. Mielniczuk, M. Pfeffer, E. Lewis, M. Blazing +6 more
2009American Society of Nephrology. Clinical Journal31 citations Open access
Semantic Scholar
Medication Discontinuation in the IMPROVE-IT Trial
A. Navar, M. Roe, Jennifer A. White, C. Cannon +7 more
2019Circulation. Cardiovascular Quality and Outcomes29 citations Open access
Semantic Scholar
Modeling Survival Distribution as a Function of Time to Treatment Discontinuation: a Dynamic Treatment Regime Approach
Shu Yang, A. Tsiatis, M. Blazing
2018Biometrics29 citations Open access
Semantic Scholar
Premature release of data from clinical trials of ezetimibe.
R. Califf, R. Harrington, M. Blazing
2009New England Journal of Medicine29 citations Open access
Semantic Scholar
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials
C. Reith, L. Blackwell, J. Emberson, D. Preiss +131 more
2026The Lancet28 citations Open access
Semantic Scholar
Is Rhythm‐Control Superior to Rate‐Control in Patients with Atrial Fibrillation and Diastolic Heart Failure?
Melissa H. Kong, L. Shaw, C. O'Connor, R. Califf +2 more
2010Annals of Noninvasive Electrocardiology27 citations Open access
Semantic Scholar
Pain Catastrophizing in Patients with Non-Cardiac Chest Pain: Relationships with Pain, Anxiety, and Disability
R. Shelby, Tamara J. Somers, F. Keefe, S. Silva +9 more
2009Psychosomatic Medicine27 citations Open access
Semantic Scholar
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
M. Blazing, R. Giugliano, J. A. de Lemos, C. Cannon +10 more
2016American Heart Journal26 citations
Semantic Scholar
Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes
Alexander C. Fanaroff, M. Roe, R. Clare, Y. Lokhnygina +6 more
2017Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease24 citations Open access
Semantic Scholar
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial
Vishal N. Rao, Anand Shah, Jaime McDermott, Stephanie G. Barnes +9 more
2022Circulation: Heart Failure23 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Cannon×29
Invite
C. Cannon — researcher profile on SciRah
E. Braunwald×27
Invite
E. Braunwald — researcher profile on SciRah
R. Giugliano×22
Invite
R. Giugliano — researcher profile on SciRah
S. Murphy×17
Invite
S. Murphy — researcher profile on SciRah

Jennifer A. White

×16

Invite

Jennifer A. White — researcher profile on SciRah

J. A. de Lemos×16

Invite

J. A. de Lemos — researcher profile on SciRah

Invite

R. Califf — researcher profile on SciRah

Invite

E. Bohula — researcher profile on SciRah

Jeong-Gun Park×12

Invite

Jeong-Gun Park — researcher profile on SciRah

A. Tershakovec×11

Invite

A. Tershakovec — researcher profile on SciRah

Invite

S. Wiviott — researcher profile on SciRah

Invite

T. Pedersen — researcher profile on SciRah